Federal Court Rules To Prohibit Access To Abortion Pill: Supreme Court To Weigh In
Portfolio Pulse from Aaron Bry
The 5th Circuit Court of Appeals has ruled to prohibit access to the abortion pill, mifepristone, in a case against the FDA. The ruling will not take effect until the Supreme Court weighs in, potentially next year. This could increase demand for birth control pills from companies like Pfizer Inc, Merck & Co Inc, and Johnson & Johnson.
August 16, 2023 | 7:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson could see increased demand for its birth control pills due to the potential prohibition of the abortion pill, mifepristone.
The court ruling against mifepristone could lead to increased demand for alternative birth control methods, such as the pills provided by Johnson & Johnson.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Merck & Co Inc could see increased demand for its birth control pills due to the potential prohibition of the abortion pill, mifepristone.
The court ruling against mifepristone could lead to increased demand for alternative birth control methods, such as the pills provided by Merck.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Pfizer could see increased demand for its birth control pills due to the potential prohibition of the abortion pill, mifepristone.
The court ruling against mifepristone could lead to increased demand for alternative birth control methods, such as the pills provided by Pfizer.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70